One Plus One Wealth Management LLC decreased its position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 89.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,541 shares of the company's stock after selling 315,374 shares during the quarter. One Plus One Wealth Management LLC owned approximately 0.76% of Nutex Health worth $815,000 at the end of the most recent quarter.
Separately, Essex Investment Management Co. LLC bought a new position in Nutex Health in the third quarter worth approximately $1,579,000. Institutional investors own 5.32% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the company. Benchmark lifted their price target on Nutex Health from $30.00 to $45.00 and gave the company a "buy" rating in a report on Wednesday, August 21st. Maxim Group assumed coverage on shares of Nutex Health in a report on Wednesday, September 18th. They issued a "buy" rating and a $45.00 price target on the stock.
Get Our Latest Report on Nutex Health
Insider Transactions at Nutex Health
In other news, CFO Jon Christian Bates purchased 1,350 shares of the company's stock in a transaction on Thursday, August 22nd. The shares were acquired at an average price of $21.46 per share, for a total transaction of $28,971.00. Following the purchase, the chief financial officer now owns 2,277 shares in the company, valued at $48,864.42. This trade represents a 100.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 38.52% of the company's stock.
Nutex Health Stock Up 8.7 %
NUTX stock traded up $2.17 on Wednesday, hitting $27.17. 49,621 shares of the company's stock were exchanged, compared to its average volume of 49,822. The firm has a 50 day moving average price of $22.20 and a two-hundred day moving average price of $13.07. The company has a debt-to-equity ratio of 3.04, a quick ratio of 1.55 and a current ratio of 1.59. Nutex Health Inc. has a 12-month low of $4.16 and a 12-month high of $42.00. The stock has a market cap of $137.75 million, a P/E ratio of -2.96 and a beta of 0.11.
Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.22. The firm had revenue of $76.08 million during the quarter. Nutex Health had a negative net margin of 13.73% and a negative return on equity of 43.79%.
About Nutex Health
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
